Abstracts - faqs.org

Abstracts

Retail industry

Search abstracts:
Abstracts » Retail industry

A drug for every bug

Article Abstract:

A vaccine is being developed that could act against asthma stimuli though it was orginally geared to hastening TB cures. The idea for the vaccine came from a study of the effectiveness of BCG vaccine against TB in Uganda, where a bacterium appears to stimulate Th1 lymphocyte production, helping the battle against infections. Children are more likely to suffer from asthma in developed economies where homes tend to be freer of germs, and draughts are prevented, so allergens stay within the home. Eastern German children suffer less from asthma and are more likely to have been in groups, exposed to infections, when they are very young.

Author: Spark, David
Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 1997
Drug therapy, Asthma

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Vaccine for plague starts human trials

Article Abstract:

Trials of bubonic plague vaccine are to be carried out by Porton Down center in Wiltshire, England. The military research center has used genetic engineering techniques to develop the vaccine which can be used for civilian and military purposes. Bubonic plague kills over 2,000 people annually. The military is seeking rapid results from the vaccine, and some vaccines take months to confer immunity. Porton Down is also developing a vaccine for gas gangrene. Iraq is one country where the bacterium causing gas gangrene is thought to be stored.

Author: Arthur, Charles
Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 1999
Product development, Biological warfare, Plague

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


UK: FEARS OVER MENINGITIS C VACCINATIONS

Article Abstract:

Concerns have been raised in the UK regarding the safety of meningitis C vaccinations for people under 18 years of age. The fears have been highlighted following the death of a 14 year old boy five days after receiving the vaccination and reports of an increase in calls about the safety of the vaccination from concerned parents. The concerns come amid a government scheme to immunise those under the age of 18 against the disease, which resulted in 75% fewer cases being registered in the UK in 1999 than the average of 3,000.

Publisher: Financial Times Ltd.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
Product standards, safety, & recalls, Marketing procedures, Safety and security measures, Vaccines industry, Biological products industry

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Biological products, Vaccines, United Kingdom
Similar abstracts:
  • Abstracts: New leader struggles to exert control. Dance for joy as dictator steps down. Chinese suffer for their success as mobs target the 'Jews of the East.' (Indonesia)
  • Abstracts: A season for (house) lovers. The great mortgage swindle. Is the Widow in the bag?
  • Abstracts: Ashcroft sold Belize passports for 33,000 pounds sterling. Shirts for the fashionable, at a price paid in human misery
  • Abstracts: UK: SALAD LINK TO SALMONELLA CASES. Shoppers to pay the price in plans for powerful food-standards agency
  • Abstracts: All gain and no pain for Diageo executives. Allied and the RSC - what a performance. BERMUDA: BACARDI CHIEF EXECUTIVE DEPARTS
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.